@article{fb4eed473c194deba3540d827f41ab1b,
title = "Impact of targeted tuberculosis vaccination among Amining population in South Africa: A model-based study",
abstract = "Optimizing the use of new tools, such as vaccines, may play a crucial role in reaching global targets for tuberculosis (TB) control. Some of the most promising candidate vaccines target adults, although high-coverage mass vaccinations may be logistically more challenging among this population than among children. Vaccine-delivery strategies that target high-risk groups or settings might yield proportionally greater impact than do those that target the general population. We developed an individual-based TB transmission model representing a hypothetical population consisting of people who worked in South African gold mines or lived in associated labor-sending communities. We simulated the implementation of a post infection adult vaccine with 60% efficacy and a mean effect duration of 10 years. We then compared the impact of a mine-targeted vaccination strategy, in which miners were vaccinated while in the mines, with that of a community-targeted strategy, in which random individuals within the labor-sending communities were vaccinated. Mine-targeted vaccination averted an estimated 0.37 TB cases per vaccine dose compared with 0.25 for community-targeted vaccination, for a relative efficacy of 1.46 (95% range, 1.13-1.91). The added benefit of mine targeted vaccination primarily reflected the disproportionate demographic burden of TB among the population of adult males as a whole. As novel vaccines for TB are developed, venue-based vaccine delivery that targets high-risk demographic groups may improve both vaccine feasibility and the impact on transmission.",
keywords = "Mathematical modeling, South African gold mines, TB vaccine, Targeted vaccination, Tuberculosis",
author = "Sourya Shrestha and Violet Chihota and White, {Richard G.} and Grant, {Alison D.} and Churchyard, {Gavin J.} and Dowdy, {David W.}",
note = "Funding Information: University, Baltimore, Maryland (Sourya Shrestha, David W. Dowdy); Aurum Institute, Johannesburg, South Africa (Violet Chihota, Gavin J. Churchyard); School of Public Health, University of the Witwatersrand, Johannesburg, South Africa (Violet Chihota, Gavin J. Churchyard); Foundation for Innovative New Diagnostics, Geneva, Switzerland (Violet Chihota); TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom (Richard G. White); TB Center, London School of Hygiene and Tropical Medicine, London, United Kingdom (Alison D. Grant); and Africa Center for Population Health, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa (Alison D. Grant). The study was supported by the Aeras Foundation. R.G.W. is funded by the United Kingdom Medical Research Council (MRC) and the United Kingdom Department for International Development (DFID) under the MRC/DFID concordat agreement that is also part of the European and Developing Countries Clinical Trials Partnership (EDCTP2) program supported by the European Union (grant MR/ P002404/1), the Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium grant OPP1084276/ OPP1135288, South Africa Modelling for Policy grant OPP1110334, Correlate of Risk Targeted Intervention Study (CORTIS) grant OPP1137034, Vaccines grant OPP1160830), and Unitaid (grants 4214-LSHTM-Sept15 and PO 8477-0-600). Conflict of interest: none declared. Publisher Copyright: {\textcopyright} The Author(s) 2017. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved.",
year = "2017",
month = dec,
day = "15",
doi = "10.1093/aje/kwx192",
language = "English (US)",
volume = "186",
pages = "1362--1369",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "12",
}